SPBC16A3.14 Antibody

What is SPBC16A3.14 and why is it important in research?

SPBC16A3.14 encodes Sup11p, an essential protein in S. pombe that is involved in cell wall formation and is crucial for β-1,6-glucan synthesis. Research on this protein is important because it provides insights into fundamental cellular processes such as cell wall integrity and septum formation. Sup11p shows significant homology to Saccharomyces cerevisiae Kre9, which is also involved in β-1,6-glucan synthesis, making it relevant for comparative studies between different yeast species . Understanding these processes has broader implications for fungal biology and potential antifungal drug development.

How do I validate an antibody against SPBC16A3.14/Sup11p?

Antibody validation requires a combination of genetic and orthogonal approaches. The gold standard for antibody validation involves using knockout (KO) cell lines as negative controls. For SPBC16A3.14/Sup11p antibody validation:

• Generate a CRISPR knockout of SPBC16A3.14 in an appropriate cell line (noting that since Sup11p is essential, this may require a conditional knockout system)

• Perform Western blot analysis with both wild-type and knockout samples

• Conduct immunoprecipitation assays to confirm specificity

• Use immunofluorescence to verify subcellular localization

This rigorous approach provides the most reliable validation, though it is more costly than orthogonal approaches . According to recent studies, antibodies validated using genetic approaches show higher reliability (89% confirmed specificity) compared to those validated using only orthogonal approaches (80% confirmed specificity) .

What expression and purification methods are recommended for SPBC16A3.14/Sup11p antibody production?

For SPBC16A3.14/Sup11p antibody production, consider these methodological approaches:

• Express recombinant fragments of Sup11p as GST-fusion peptides in E. coli

• Purify using affinity chromatography with glutathione-sepharose columns

• Use the purified fusion proteins for immunization

• Affinity-purify the resulting polyclonal antibodies against the original antigen

This approach has been successfully used for producing antibodies against S. pombe proteins as described in research methodology sections . For optimal results, selecting unique epitopes within the luminal domain of Sup11p is recommended since it is a membrane protein with specific topology .

How should I design experiments to study SPBC16A3.14/Sup11p localization in S. pombe?

When designing experiments to study Sup11p localization:

• Create epitope-tagged versions (e.g., HA-tagged) of Sup11p expressed from its native promoter

• Complement with fluorescent protein fusions for live-cell imaging

• Use spheroplasting techniques to preserve membrane structures

• Perform proteinase K protection assays to determine protein topology

• Include appropriate organelle markers for co-localization studies

Research indicates that Sup11p resides in the late Golgi or post-Golgi compartments, with its functional domain oriented toward the lumen . This topology information is crucial for designing meaningful localization experiments. When using fluorescent protein fusions, consider that Sup11p has a signal anchor sequence that affects its membrane orientation .

What are the recommended methods for quantifying changes in SPBC16A3.14/Sup11p expression levels?

For quantifying Sup11p expression levels:

• Western blot analysis with densitometry

• Quantitative proteomic approaches

• qRT-PCR for mRNA expression

• Consider using internal standards and normalization controls

Quantitative proteomic analysis has been successfully used to analyze chromatin-bound proteins in S. pombe . When applying these methods to Sup11p studies, sample preparation must account for its membrane-bound nature. For Western blot analysis, careful optimization of detergent conditions is necessary to efficiently extract membrane proteins while preserving epitope recognition .

How can I determine if my SPBC16A3.14 antibody cross-reacts with other proteins?

To assess potential cross-reactivity:

• Test the antibody against lysates from organisms lacking SPBC16A3.14 homologs

• Perform immunoprecipitation followed by mass spectrometry to identify all captured proteins

• Pre-absorb the antibody with recombinant antigen and test for elimination of all signals

• Use epitope mapping to confirm specificity to unique regions

Cross-reactivity testing is essential, as studies have shown that many commercial antibodies recognize unintended targets. In standardized validation tests, approximately 20% of antibodies tested against genetic knockout controls failed to show the expected specificity . For S. pombe proteins like Sup11p, testing against S. cerevisiae lysates can help identify potential cross-reactivity with homologs like Kre9 .

What are the major challenges in working with SPBC16A3.14/Sup11p antibodies?

Major challenges include:

• The essential nature of the gene makes knockout-based validation difficult

• Membrane localization requires specialized extraction protocols

• Post-translational modifications (particularly O-mannosylation) may affect epitope recognition

• Cross-reactivity with homologous proteins in related species

Research has shown that Sup11p is O-mannosylated, which can mask epitopes and affect antibody recognition . Additionally, its expression influences the growth of O-mannosyl transferase mutants, suggesting complex regulatory relationships that may affect experimental outcomes . Using conditional expression systems (e.g., nmt81 promoter) rather than complete knockouts may help overcome challenges related to its essential nature .

How can I troubleshoot weak or inconsistent signals when using SPBC16A3.14 antibodies?

Troubleshooting approaches:

• Optimize protein extraction methods for membrane proteins

  • Test different detergent combinations (e.g., CHAPS, NP-40, Triton X-100)

  • Consider specialized membrane protein extraction kits

• Evaluate fixation and permeabilization conditions

  • For S. pombe cells, test different cell wall digestion methods

  • Optimize spheroplasting protocols to maintain protein epitopes

• Test signal amplification methods

  • Consider using biotin-streptavidin systems

  • Evaluate TSA (tyramide signal amplification) for immunofluorescence

• Check for post-translational modifications

  • Sup11p is known to be O-mannosylated, which may affect epitope accessibility

  • Consider deglycosylation treatments like EndoH to improve detection

What controls should be included when using SPBC16A3.14 antibodies in different applications?

Essential controls include:

• For Western blotting:

  • Positive control: overexpression lysate

  • Negative control: conditional depletion strain

  • Loading control: established S. pombe housekeeping protein

  • Pre-immune serum control for polyclonal antibodies

• For immunoprecipitation:

  • Input sample

  • IgG control

  • Beads-only control

  • Non-specific target control

• For immunofluorescence:

  • Secondary antibody-only control

  • Known localization marker

  • Pre-absorption control with recombinant antigen

According to antibody validation studies, these controls are essential for establishing specificity, with genetic knockout or depletion controls providing the most reliable validation .

How can SPBC16A3.14 antibodies be used to study protein-protein interactions?

Methodological approaches:

• Co-immunoprecipitation followed by mass spectrometry

  • Use crosslinking agents to stabilize transient interactions

  • Consider proximity-based labeling methods like BioID or APEX

• Chromatin immunoprecipitation for DNA-protein interactions

  • Particularly relevant as proteomic studies have identified chromatin-bound proteins in S. pombe

  • Optimize crosslinking conditions for membrane-associated factors

• Proximity ligation assays (PLA)

  • Useful for detecting interactions in situ

  • Requires antibodies from different species for protein pairs

• FRET/FLIM with antibody-based detection

  • For live-cell interaction studies

  • Can be combined with super-resolution microscopy

These approaches can help elucidate Sup11p's role in cell wall formation and β-1,6-glucan synthesis networks by identifying interaction partners .

What role does SPBC16A3.14/Sup11p play in cell wall formation and how can antibodies help study this process?

Sup11p is crucial for cell wall integrity and β-1,6-glucan synthesis in S. pombe. Antibodies can help study this process through:

• Immunoelectron microscopy to visualize Sup11p localization relative to cell wall structures

• Co-immunoprecipitation to identify interactions with known cell wall synthesis machinery

• Chromatin immunoprecipitation to identify potential transcriptional regulation of cell wall genes

• Time-course immunostaining during cell cycle to map dynamic changes

Research has shown that Sup11p depletion induces significant cell wall remodeling processes, affecting the expression of multiple glucanases and glucan synthesis enzymes . Antibodies can help track these changes and identify the specific mechanisms involved.

How can I use SPBC16A3.14 antibodies in combination with proteomics approaches?

Integrated antibody-proteomic approaches:

• Antibody-based enrichment prior to mass spectrometry

  • Immunoprecipitation of Sup11p complexes followed by MS/MS analysis

  • ChIP-MS to identify chromatin-associated complexes

• Targeted proteomics with antibody validation

  • Selected reaction monitoring (SRM) or parallel reaction monitoring (PRM)

  • Absolute quantification using isotope-labeled peptide standards

• Spatial proteomics

  • Combine immunofluorescence with laser capture microdissection

  • Correlative microscopy with region-specific proteomics

• Post-translational modification mapping

  • Immunoprecipitate Sup11p and analyze glycosylation patterns

  • Phosphorylation state analysis in different cellular conditions

Quantitative proteomic analysis has been successfully implemented for studying chromatin-bound proteins in S. pombe , and similar approaches could be applied to membrane proteins like Sup11p with appropriate modifications to extraction protocols.

Can SPBC16A3.14 antibodies be used in biomarker development similar to other protein-targeted antibodies?

While SPBC16A3.14 is a yeast protein, methodological lessons from other protein-targeted antibody biomarkers are applicable:

• Establish specificity and sensitivity benchmarks through rigorous validation

• Develop standardized detection protocols across different laboratories

• Use multiplexed detection systems to improve diagnostic accuracy

• Consider antibody engineering approaches to improve affinity and specificity

Studies of antibodies as biomarkers, such as anti-p16 antibodies in non-small cell lung cancer, demonstrate the importance of standardized ELISA protocols with CV values below 15% for reproducibility . Such methodological rigor would be essential if developing SPBC16A3.14-derived applications beyond basic research.

What are the considerations for developing monoclonal versus polyclonal antibodies against SPBC16A3.14/Sup11p?

Key considerations include:

• Monoclonal antibodies:

  • Advantages: Consistent performance between batches, high specificity

  • Disadvantages: May be sensitive to epitope modifications, potentially lower sensitivity

  • Best applications: Quantitative assays, specific domain recognition

• Polyclonal antibodies:

  • Advantages: Robust signal, recognize multiple epitopes

  • Disadvantages: Batch-to-batch variation, potential cross-reactivity

  • Best applications: Initial characterization, detection of denatured proteins

• Development strategy:

  • Epitope selection should consider Sup11p's membrane topology and known O-mannosylation sites

  • For polyclonal antibodies, affinity purification against specific epitopes can improve specificity

  • For monoclonals, screening against both native and denatured forms ensures versatility

Recent studies show that antibody validation using genetic approaches significantly improves reliability regardless of antibody type, with 89% of genetically validated antibodies confirmed as specific .

How might CRISPR/Cas9 genome editing technologies enhance SPBC16A3.14 antibody validation and application?

CRISPR/Cas9 technologies offer several advantages:

• Generation of precise knockout controls

  • For essential genes like SPBC16A3.14, conditional or auxin-inducible degron approaches

  • Creation of epitope-tagged endogenous versions for antibody validation

• Engineering specific mutations to test antibody epitope binding

  • Systematic modification of potential epitopes to map antibody binding sites

  • Introduction of mutations that mimic post-translational modifications

• Creation of reporter cell lines

  • Knock-in fluorescent proteins for correlation with antibody staining

  • Development of split-reporter systems to study protein interactions

• Multiplexed validation systems

  • Pooled CRISPR screens to test multiple antibodies simultaneously

  • Barcoded cell libraries with different SPBC16A3.14 modifications

Studies have shown that using CRISPR knockout cells as validation controls provides the most rigorous assessment of antibody specificity, with this approach considered the gold standard in the field .